1. |
Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 1992, 101(6): 1644-1655.
|
2. |
Stevenson EK, Rubenstein AR, Radin GT, et al. Two decades of mortality trends among patients with severe sepsis: a comparative meta-analysis. Crit Care Med, 2014, 42(3): 625-631.
|
3. |
Heumann D, Glauser MP, Calandra T. Molecular basis of host-pathogen interaction in septic shock. Curr Opin Microbiol, 1998, 1(1): 49-55.
|
4. |
Danner RL, Elin RJ, Hosseini JM, et al. Endotoxemia in human septic shock. Chest, 1991, 99(1): 169-175.
|
5. |
Baranowsky A, Appelt J, Kleber C, et al. Procalcitonin exerts a mediator role in septic shock through the calcitonin gene-related peptide receptor. Crit Care Med, 2021, 49(1): e41-e52.
|
6. |
Nemoto H, Nakamoto H, Okada H, et al. Newly developed immobilized polymyxin B fibers improve the survival of patients with sepsis. Blood Purif, 2001, 19(4): 361-368.
|
7. |
Chang T, Tu YK, Lee CT, et al. Effects of polymyxin B hemoperfusion on mortality in patients with severe sepsis and septic shock: a systemic review, meta-analysis update, and disease severity subgroup meta-analysis. Crit Care Med, 2017, 45(8): e858-e864.
|
8. |
Kuriyama A, Katsura M, Urushidani S, et al. Impact of polymyxin B hemoperfusion in the treatment of patients with sepsis and septic shock: a meta-analysis of randomized controlled trials. Ann Transl Med, 2018, 6(11): 206.
|
9. |
Honore PM, Hoste E, Molnár Z, et al. Cytokine removal in human septic shock: where are we and where are we going?. Ann Intensive Care, 2019, 9(1): 56.
|
10. |
中国医师协会急诊医师分会, 中国研究型医院学会休克与脓毒症专业委员会. 中国脓毒症/脓毒性休克急诊治疗指南(2018). 中国急救医学, 2018, 28(9): 741-756.
|
11. |
Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Intensive Care Med, 2017, 43(3): 304-377.
|
12. |
Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ ATS/SIS international sepsis definitions conference. Crit Care Med, 2003, 31(4): 1250-1256.
|
13. |
Singer M, Deutschman CS, Seymour CW, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA, 2016, 315(8): 801-810.
|
14. |
田兴国, 陈志, 贺慧为, 等. 多黏菌素B血液灌流对脓毒症和脓毒症休克患者预后影响的荟萃分析. 中国呼吸与危重监护杂志, 2020, 19(1): 16-21.
|
15. |
Ono S, Tsujimoto H, Matsumoto A, et al. Modulation of human leukocyte antigen-DR on monocytes and CD16 on granulocytes in patients with septic shock using hemoperfusion with polymyxin B-immobilized fiber. Am J Surg, 2004, 188(2): 150-156.
|
16. |
Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature, 2000, 406(6797): 782-787.
|
17. |
Nishibori M, Takahashi HK, Katayama H, et al. Specific removal of monocytes from peripheral blood of septic patients by polymyxin B-immobilized filter column. Acta Med Okayama, 2009, 63(1): 65-69.
|
18. |
Coudroy R, Payen D, Launey Y, et al. Modulation by polymyxin-B hemoperfusion of inflammatory response related to severe peritonitis. Shock, 2017, 47(1): 93-99.
|
19. |
Becker KL, Snider R, Nylen ES. Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations. Crit Care Med, 2008, 36(3): 941-952.
|
20. |
Remick DG. Pathophysiology of sepsis. Am J Pathol, 2007, 170(5): 1435-1444.
|
21. |
Evans L, Rhodes A, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. Intensive Care Med, 2021, 47(11): 1181-1247.
|
22. |
Hawchar F, László I, Öveges N, et al. Extracorporeal cytokine adsorption in septic shock: a proof of concept randomized, controlled pilot study. J Crit Care, 2019, 49: 172-178.
|
23. |
Rybalko A, Voronin A, Vagulin A, et al. Early use of cytokine adsorption in treatment of COVID-19 associated respiratory distress syndrome. Medicinskij alfavit, 2022, 1(17): 71-75.
|